These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

427 related items for PubMed ID: 19006186

  • 1. Clinical pattern and risk factors for dyskinesias following fetal nigral transplantation in Parkinson's disease: a double blind video-based analysis.
    Olanow CW, Gracies JM, Goetz CG, Stoessl AJ, Freeman T, Kordower JH, Godbold J, Obeso JA.
    Mov Disord; 2009 Feb 15; 24(3):336-43. PubMed ID: 19006186
    [Abstract] [Full Text] [Related]

  • 2. Sarizotan as a treatment for dyskinesias in Parkinson's disease: a double-blind placebo-controlled trial.
    Goetz CG, Damier P, Hicking C, Laska E, Müller T, Olanow CW, Rascol O, Russ H.
    Mov Disord; 2007 Jan 15; 22(2):179-86. PubMed ID: 17094088
    [Abstract] [Full Text] [Related]

  • 3. Deep brain stimulation in Parkinson's disease following fetal nigral transplantation.
    Herzog J, Pogarell O, Pinsker MO, Kupsch A, Oertel WH, Lindvall O, Deuschl G, Volkmann J.
    Mov Disord; 2008 Jul 15; 23(9):1293-6. PubMed ID: 18536037
    [Abstract] [Full Text] [Related]

  • 4. Bilateral subthalamotomy in Parkinson's disease: initial and long-term response.
    Alvarez L, Macias R, Lopez G, Alvarez E, Pavon N, Rodriguez-Oroz MC, Juncos JL, Maragoto C, Guridi J, Litvan I, Tolosa ES, Koller W, Vitek J, DeLong MR, Obeso JA.
    Brain; 2005 Mar 15; 128(Pt 3):570-83. PubMed ID: 15689366
    [Abstract] [Full Text] [Related]

  • 5. [Dyskinesia caused by L-DOPA].
    Derkinderen P, Vidailhet M.
    Rev Neurol (Paris); 2002 Dec 15; 158 Spec no 1():S92-101. PubMed ID: 12690668
    [Abstract] [Full Text] [Related]

  • 6. Repetitive transcranial magnetic stimulation for levodopa-induced dyskinesias in Parkinson's disease.
    Filipović SR, Rothwell JC, van de Warrenburg BP, Bhatia K.
    Mov Disord; 2009 Jan 30; 24(2):246-53. PubMed ID: 18951540
    [Abstract] [Full Text] [Related]

  • 7. [Social and economic cost of L-Dopa-induced dyskinesias in patients with Parkinson's disease].
    Maurel F, Lilliu H, Le Pen C.
    Rev Neurol (Paris); 2001 May 30; 157(5):507-14. PubMed ID: 11438770
    [Abstract] [Full Text] [Related]

  • 8. Levodopa-associated dyskinesia risk among Parkinson disease patients in Olmsted County, Minnesota, 1976-1990.
    Van Gerpen JA, Kumar N, Bower JH, Weigand S, Ahlskog JE.
    Arch Neurol; 2006 Feb 30; 63(2):205-9. PubMed ID: 16476808
    [Abstract] [Full Text] [Related]

  • 9. A double-blind controlled trial of bilateral fetal nigral transplantation in Parkinson's disease.
    Olanow CW, Goetz CG, Kordower JH, Stoessl AJ, Sossi V, Brin MF, Shannon KM, Nauert GM, Perl DP, Godbold J, Freeman TB.
    Ann Neurol; 2003 Sep 30; 54(3):403-14. PubMed ID: 12953276
    [Abstract] [Full Text] [Related]

  • 10. Effect of memantine (NMDA antagonist) on Parkinson's disease: a double-blind crossover randomized study.
    Merello M, Nouzeilles MI, Cammarota A, Leiguarda R.
    Clin Neuropharmacol; 1999 Sep 30; 22(5):273-6. PubMed ID: 10516877
    [Abstract] [Full Text] [Related]

  • 11. Continuous subcutaneous apomorphine therapy improves dyskinesias in Parkinson's disease: a prospective study using single-dose challenges.
    Katzenschlager R, Hughes A, Evans A, Manson AJ, Hoffman M, Swinn L, Watt H, Bhatia K, Quinn N, Lees AJ.
    Mov Disord; 2005 Feb 30; 20(2):151-7. PubMed ID: 15390035
    [Abstract] [Full Text] [Related]

  • 12. Adding a dopamine agonist to preexisting levodopa therapy vs. levodopa therapy alone in advanced Parkinson's disease: a meta analysis.
    Talati R, Baker WL, Patel AA, Reinhart K, Coleman CI.
    Int J Clin Pract; 2009 Apr 30; 63(4):613-23. PubMed ID: 19222614
    [Abstract] [Full Text] [Related]

  • 13. Early morning off-medication dyskinesias, dystonia, and choreic subtypes.
    Cubo E, Gracies JM, Benabou R, Olanow CW, Raman R, Leurgans S, Goetz CG.
    Arch Neurol; 2001 Sep 30; 58(9):1379-82. PubMed ID: 11559308
    [Abstract] [Full Text] [Related]

  • 14. Evaluating Parkinson's disease patients at home: utility of self-videotaping for objective motor, dyskinesia, and ON-OFF assessments.
    Goetz CG, Leurgans S, Hinson VK, Blasucci LM, Zimmerman J, Fan W, Nguyen T, Hsu A.
    Mov Disord; 2008 Jul 30; 23(10):1479-82. PubMed ID: 18512751
    [Abstract] [Full Text] [Related]

  • 15. Slow oscillatory activity and levodopa-induced dyskinesias in Parkinson's disease.
    Alonso-Frech F, Zamarbide I, Alegre M, Rodríguez-Oroz MC, Guridi J, Manrique M, Valencia M, Artieda J, Obeso JA.
    Brain; 2006 Jul 30; 129(Pt 7):1748-57. PubMed ID: 16684788
    [Abstract] [Full Text] [Related]

  • 16. Risk factors in development of motor complications in Chinese patients with idiopathic Parkinson's disease.
    Kum WF, Gao J, Durairajan SS, Man SC, Xie LX, Lu JH, Fong WL, Li M.
    J Clin Neurosci; 2009 Aug 30; 16(8):1034-7. PubMed ID: 19428256
    [Abstract] [Full Text] [Related]

  • 17. Quantifying drug-induced dyskinesias in the arms using digitised spiral-drawing tasks.
    Liu X, Carroll CB, Wang SY, Zajicek J, Bain PG.
    J Neurosci Methods; 2005 May 15; 144(1):47-52. PubMed ID: 15848238
    [Abstract] [Full Text] [Related]

  • 18. Rating scales for dyskinesias in Parkinson's disease.
    Goetz CG.
    Mov Disord; 1999 May 15; 14 Suppl 1():48-53. PubMed ID: 10493403
    [No Abstract] [Full Text] [Related]

  • 19. Dyskinesias predict the onset of motor response fluctuations in patients with Parkinson's disease on L-dopa monotherapy.
    Mazzella L, Yahr MD, Marinelli L, Huang N, Moshier E, Di Rocco A.
    Parkinsonism Relat Disord; 2005 May 15; 11(3):151-5. PubMed ID: 15823479
    [Abstract] [Full Text] [Related]

  • 20. Reducing dosing frequency of carbidopa/levodopa: double-blind crossover study comparing twice-daily bilayer formulation of carbidopa/levodopa (IPX054) versus 4 daily doses of standard carbidopa/levodopa in stable Parkinson disease patients.
    Hinson VK, Goetz CG, Leurgans S, Fan W, Nguyen T, Hsu A.
    Clin Neuropharmacol; 2009 May 15; 32(4):189-92. PubMed ID: 19620848
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.